Coarse-grained molecular dynamics of ligands binding into protein: The case of HIV-1 protease inhibitors

被引:28
作者
Li, Dechang [2 ]
Liu, Ming S. [1 ,3 ]
Ji, Baohua [2 ]
Hwang, Kehchih [2 ]
Huang, Yonggang [4 ]
机构
[1] Swinburne Univ Technol, Ctr Mol Simulat, POB 218, Hawthorn, Vic 3122, Australia
[2] Tsinghua Univ, Sch Aerosp, Dept Engn Mech, Beijing 100084, Peoples R China
[3] CSIRO Math & Informat Sci, Clayton, Vic 3169, Australia
[4] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA
基金
中国国家自然科学基金;
关键词
Boltzmann equation; bonds (chemical); diseases; drugs; microorganisms; molecular biophysics; molecular dynamics method; Poisson equation; proteins; solvation; ENZYMATIC-REACTION; SUBSTRATE-BINDING; FREE-ENERGIES; ALPHA-HELIX; MECHANISM; RESISTANT; SIMULATION; MODEL; FLAPS; ELECTROSTATICS;
D O I
10.1063/1.3148022
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Binding dynamics and pathways of ligands or inhibitors to target proteins are challenging both experimental and theoretical biologists. A dynamics understanding of inhibitors interacting with protein is essential for the design of novel potent drugs. In this work we applied a coarse-grained molecular dynamics method for simulating inhibitors entering the binding cavity of human immunodeficiency virus type 1 protease (PR). It shows that the coarse-grained dynamics, consistent with the experimental results, can capture the essential molecular dynamics of various inhibitors binding into PR. The primary driving force for the binding processes is the nonbond interaction between inhibitors and PR. The size and topology of inhibitors and the interacting strength between inhibitors and PR have great influence on the binding mode and processes. The interaction strength between the PR and various inhibitors is also analyzed by atomistic molecular mechanics and Poisson-Boltzmann solvation area method.
引用
收藏
页数:10
相关论文
共 90 条
[51]   FLEXIBILITY AND FUNCTION IN HIV-1 PROTEASE [J].
NICHOLSON, LK ;
YAMAZAKI, T ;
TORCHIA, DA ;
GRZESIEK, S ;
BAX, A ;
STAHL, SJ ;
KAUFMAN, JD ;
WINGFIELD, PT ;
LAM, PYS ;
JADHAV, PK ;
HODGE, CN ;
DOMAILLE, PJ ;
CHANG, CH .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (04) :274-280
[52]   Thermodynamic rules for the design of high affinity HIV-1 protease inhibitors with adaptability to mutations and high selectivity towards unwanted targets [J].
Ohtaka, H ;
Muzammil, S ;
Schön, A ;
Velazquez-Campoy, A ;
Vega, S ;
Freire, E .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (09) :1787-1799
[53]   Role of conformational fluctuations in the enzymatic reaction of HIV-1 protease [J].
Piana, S ;
Carloni, P ;
Parrinello, M .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 319 (02) :567-583
[54]   How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease [J].
Prabu-Jeyabalan, M ;
Nalivaika, E ;
Schiffer, CA .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 301 (05) :1207-1220
[55]   UFF, A FULL PERIODIC-TABLE FORCE-FIELD FOR MOLECULAR MECHANICS AND MOLECULAR-DYNAMICS SIMULATIONS [J].
RAPPE, AK ;
CASEWIT, CJ ;
COLWELL, KS ;
GODDARD, WA ;
SKIFF, WM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (25) :10024-10035
[56]   Residue-residue mean-force potentials for protein structure recognition [J].
Reva, BA ;
Finkelstein, AV ;
Sanner, MF ;
Olson, AJ .
PROTEIN ENGINEERING, 1997, 10 (08) :865-876
[57]  
Rick SW, 1998, PROTEINS, V32, P7, DOI 10.1002/(SICI)1097-0134(19980701)32:1<7::AID-PROT3>3.0.CO
[58]  
2-K
[59]   DEVELOPMENT OF DRUG-RESISTANCE TO HIV-1 PROTEASE INHIBITORS [J].
RIDKY, T ;
LEIS, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (50) :29621-29623
[60]   INHIBITOR BINDING TO THE PHE53TRP MUTANT OF HIV-1 PROTEASE PROMOTES CONFORMATIONAL-CHANGES DETECTABLE BY SPECTROFLUOROMETRY [J].
RODRIGUEZ, EJ ;
DEBOUCK, C ;
DECKMAN, IC ;
ABUSOUD, H ;
RAUSHEL, FM ;
MEEK, TD .
BIOCHEMISTRY, 1993, 32 (14) :3557-3563